EGFR and cancer: We identified protein kinases in need of further curation as well as kinase functional domains where aberrant PTM may contribute to disease; furthermore, we proposed testable hypotheses about cancer variants altering key PTM sites and experimentally tested the hypotheses in EGFR and PKCβ.